FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048022317> ?p ?o ?g. }

• W3048022317 endingPage "72" @default.
• W3048022317 startingPage "62" @default.
• W3048022317 abstract "Treatment with sodium-glucose co-transporter-2-inhibitors (SGLT2-Is), such as canagliflozin, has been associated with an increased risk of lower limb amputations (LLAs) in type 2 diabetes mellitus (T2DM). However, conflicting results have been reported for different SGLT2-Is and the underlying mechanism is unclear.To investigate the risk of LLA and diabetic foot ulcer with SGLT2-I use compared to other anti-diabetic drugs and to explore hypovolemia as a potential underlying mechanism.A cohort study was conducted using data from the Clinical Practice Research Datalink GOLD (2013-2019). The study population (N=51,847) consisted of T2DM patients over 18 years of age with at least one prescription of a non-insulin anti-diabetic drug. Concomitant diuretic use and the presence of signs of hypovolemia were determined to assess the potential underlying mechanism. Cox proportional hazard models were used to estimate the hazard ratio (HR) for LLA in current SGLT2-I use versus current sulphonylurea (SU) use. Analyses were adjusted for lifestyle variables, comorbidities, and concomitant drug use.Current SGLT2-I use was not associated with an increased risk of LLA compared to current SU use (fully adjusted HR 0.70; 95% confidence interval 0.38-1.29). Concomitant use of diuretics and the presence of signs of hypovolemia were not associated with an increased risk of LLA.Use of SGLT2-Is, with or without signs of hypovolemia, was not associated with an increased risk of LLA or DFU versus current SU use. Future studies powered to detect potential differences between individual SGLT2-Is are required to rule out a canagliflozin-specific effect." @default.
• W3048022317 created "2020-08-13" @default.
• W3048022317 creator A5015740722 @default.
• W3048022317 creator A5025902169 @default.
• W3048022317 creator A5032185441 @default.
• W3048022317 creator A5034083636 @default.
• W3048022317 creator A5035915818 @default.
• W3048022317 creator A5038582571 @default.
• W3048022317 creator A5038962814 @default.
• W3048022317 creator A5039354063 @default.
• W3048022317 creator A5051231925 @default.
• W3048022317 creator A5064914075 @default.
• W3048022317 creator A5086210130 @default.
• W3048022317 date "2021-03-12" @default.
• W3048022317 modified "2023-09-27" @default.
• W3048022317 title "Use of Sodium-Glucose Co-Transporter-2-Inhibitors (SGLT2-Is) and Risk of Lower Limb Amputation" @default.
• W3048022317 cites W1683871895 @default.
• W3048022317 cites W2006236530 @default.
• W3048022317 cites W2008706768 @default.
• W3048022317 cites W2059439623 @default.
• W3048022317 cites W2115626618 @default.
• W3048022317 cites W2119852447 @default.
• W3048022317 cites W2126861389 @default.
• W3048022317 cites W2147222003 @default.
• W3048022317 cites W2151345870 @default.
• W3048022317 cites W2605684169 @default.
• W3048022317 cites W2626446274 @default.
• W3048022317 cites W2653321410 @default.
• W3048022317 cites W2731777658 @default.
• W3048022317 cites W2736492270 @default.
• W3048022317 cites W2756318809 @default.
• W3048022317 cites W2756910166 @default.
• W3048022317 cites W2766110291 @default.
• W3048022317 cites W2768451744 @default.
• W3048022317 cites W2780645176 @default.
• W3048022317 cites W2789727438 @default.
• W3048022317 cites W2792252004 @default.
• W3048022317 cites W2810458929 @default.
• W3048022317 cites W2810587401 @default.
• W3048022317 cites W2884954235 @default.
• W3048022317 cites W2886009800 @default.
• W3048022317 cites W2899844209 @default.
• W3048022317 cites W2900732862 @default.
• W3048022317 cites W2913973787 @default.
• W3048022317 cites W2916920217 @default.
• W3048022317 cites W2931787950 @default.
• W3048022317 cites W2972290078 @default.
• W3048022317 doi "https://doi.org/10.2174/1574886315666200805103053" @default.
• W3048022317 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32767909" @default.
• W3048022317 hasPublicationYear "2021" @default.
• W3048022317 type Work @default.
• W3048022317 sameAs 3048022317 @default.
• W3048022317 citedByCount "7" @default.
• W3048022317 countsByYear W30480223172021 @default.
• W3048022317 countsByYear W30480223172022 @default.
• W3048022317 countsByYear W30480223172023 @default.
• W3048022317 crossrefType "journal-article" @default.
• W3048022317 hasAuthorship W3048022317A5015740722 @default.
• W3048022317 hasAuthorship W3048022317A5025902169 @default.
• W3048022317 hasAuthorship W3048022317A5032185441 @default.
• W3048022317 hasAuthorship W3048022317A5034083636 @default.
• W3048022317 hasAuthorship W3048022317A5035915818 @default.
• W3048022317 hasAuthorship W3048022317A5038582571 @default.
• W3048022317 hasAuthorship W3048022317A5038962814 @default.
• W3048022317 hasAuthorship W3048022317A5039354063 @default.
• W3048022317 hasAuthorship W3048022317A5051231925 @default.
• W3048022317 hasAuthorship W3048022317A5064914075 @default.
• W3048022317 hasAuthorship W3048022317A5086210130 @default.
• W3048022317 hasBestOaLocation W30480223172 @default.
• W3048022317 hasConcept C126322002 @default.
• W3048022317 hasConcept C134018914 @default.
• W3048022317 hasConcept C207103383 @default.
• W3048022317 hasConcept C2777180221 @default.
• W3048022317 hasConcept C2777451236 @default.
• W3048022317 hasConcept C2779384505 @default.
• W3048022317 hasConcept C2781309813 @default.
• W3048022317 hasConcept C2908647359 @default.
• W3048022317 hasConcept C44249647 @default.
• W3048022317 hasConcept C555293320 @default.
• W3048022317 hasConcept C71924100 @default.
• W3048022317 hasConcept C99454951 @default.
• W3048022317 hasConceptScore W3048022317C126322002 @default.
• W3048022317 hasConceptScore W3048022317C134018914 @default.
• W3048022317 hasConceptScore W3048022317C207103383 @default.
• W3048022317 hasConceptScore W3048022317C2777180221 @default.
• W3048022317 hasConceptScore W3048022317C2777451236 @default.
• W3048022317 hasConceptScore W3048022317C2779384505 @default.
• W3048022317 hasConceptScore W3048022317C2781309813 @default.
• W3048022317 hasConceptScore W3048022317C2908647359 @default.
• W3048022317 hasConceptScore W3048022317C44249647 @default.
• W3048022317 hasConceptScore W3048022317C555293320 @default.
• W3048022317 hasConceptScore W3048022317C71924100 @default.
• W3048022317 hasConceptScore W3048022317C99454951 @default.
• W3048022317 hasIssue "1" @default.
• W3048022317 hasLocation W30480223171 @default.
• W3048022317 hasLocation W30480223172 @default.
• W3048022317 hasLocation W30480223173 @default.
• W3048022317 hasLocation W30480223174 @default.

• next